Contacts

Doctor Daniela van Santen

Postdoctoral fellow

Background

Daniëla Katinka van Santen earned her bachelor’s degree in Nursing and soon after completed the pre-master Health Sciences at the VU University of Amsterdam. In 2012 she completed her master’s internship at the Public Health Service of Amsterdam (GGD Amsterdam) and the Royal Tropical Institute (KIT). In 2012 she obtained a cum laude master’s degree in Health Sciences, specialising in infectious diseases.

In May 2018, Daniëla completed her PhD training at the department of Infectious Disease Research and Prevention at the Public Health Service of Amsterdam under the supervision of Prof. Maria Prins, Dr. Ronald Geskus and Dr. Jannie van der Helm. Her PhD thesis is titled “Epidemiological studies on viral infections and co-infections: human immunodeficiency virus, hepatitis C virus and human papillomavirus”.

In 2016 she worked at the same institution as a researcher in the department of Epidemiology, Health Promotion and Care Innovation on the Amsterdam Health Monitoring study. Currently, Daniëla is working as a post-doctoral fellow at the Public Health Service of Amsterdam and the Burnet Institute.

Key interests: viral infections and co-infections (i.e. HIV and hepatitis C co-infection) affecting key populations such as gay and bisexual men and people who inject drugs. As well as public health and complex epidemiological and statistical methods to analyse longitudinal data.

Key projects:

  • International Collaboration on Hepatitis C Elimination in HIV –Coinfection (InCHEHC) – including 11 HIV cohorts from 7 countries.
  • HIV and HCV co-infection elimination among gay and bisexual men in Australia.
  • Harm reduction revisited: assessing the causal effect of harm reductions programs on - - HIV and HCV acquisition among people who inject drugs. This is also a collaborative project, which will include data from the Amsterdam Cohort Studies (Public Health Service of Amsterdam, Amsterdam) the SuperMix cohort (Burnet Institute, Melbourne) and ALIVE cohort (Johns Hopkins University, Baltimore).

Positions

  • 2017 – ongoing: Postdoctoral fellow at the Public Health Service of Amsterdam, the Netherlands
  • 2018 – ongoing: Postdoctoral fellow at Burnet Institute, Melbourne, Australia

Qualifications

2018: PhD, University of Amsterdam, the Netherlands 2012: MSc, VU university, Amsterdam, the Netherlands 2010: BSc, Utrecht University of applied sciences, Utrecht, the Netherlands

Awards

  • 2017: Spinoza travel award (Amsterdams Universiteit fonds) to attend the 6th International Symposium on Hepatitis Care in Substance Users (INHSU) – New York, USA
  • 2017: Amsterdam Infection and Immunity travel grant – to attend the 20th International Workshop on HIV and Hepatitis Observational Databases (IWHOD) – Lisbon, Portugal
  • 2017: Young investigator registration bursary – European Association for the Study of the Liver (EASL) – Amsterdam, the Netherlands
  • 2016: Full scholarship award – 5th International Symposium on Hepatitis Care in Substance Users (INHSU) – Oslo, Norway
  • 2016: Young investigator scholarship award – 21st AIDS conference – Durban, South Africa
  • 2015: Best poster presentation – 15th European AIDS Conference (EACS), – Barcelona, Spain
  • 2015: AMC young talent fund Louise Gunning Public Health Study Fund, specific Public Health course at Johns Hopkins University – Baltimore, USA
  • 2015: Full scholarship award – 4th International Symposium on Hepatitis Care in Substance Users (INHSU) – Sydney, Australia
  • 2014: Young investigator scholarship award – 21st Conference on Retroviruses and Opportunistic Infections (CROI) – Boston, USA

Publications (13)

2018 (2)

2017 (3)

2016 (3)

2015 (4)

  • The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms.
    S B Willemse, D Razavi-Shearer, F R Zuure, I K Veldhuijzen, E A Croes, A J van der Meer, D K van Santen, J M de Vree, R J de Knegt, H L Zaaijer, H W Reesink, M Prins, H Razavi
    Neth J Med. 2015 Nov; 73(9):417-431
  • Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2.
    V Saraswat, S Norris, R J de Knegt, J F Sanchez Avila, M Sonderup, E Zuckerman, P Arkkila, C Stedman, S Acharya, I Aho, A C Anand, M I Andersson, V Arendt, O Baatarkhuu, K Barclay, Z Ben-Ari, C Bergin, F Bessone, S Blach, N Blokhina, C R Brunton, G Choudhuri, V Chulanov, L Cisneros, E A Croes, Y A Dahgwahdorj, O Dalgard, J R Daruich, N R Dashdorj, D Davaadorj, M de Vree, C Estes, R Flisiak, A C Gadano, E Gane, W Halota, A Hatzakis, C Henderson, P Hoffmann, J Hornell, D Houlihan, S Hrusovsky, P Jarcuska, D Kershenobich, K Kostrzewska, P Kristian, M Leshno, Y Lurie, A Mahomed, N Mamonova, N Mendez-Sanchez, J Mossong, E Nurmukhametova, P Nymadawa, M Oltman, J Oyunbileg, Ts Oyunsuren, G Papatheodoridis, N Pimenov, N Prabdial-Sing, M Prins, P Puri, S Radke, A Rakhmanova, H Razavi, K Razavi-Shearer, H W Reesink, E Ridruejo, R Safadi, O Sagalova, R Sanduijav, I Schreter, C Seguin-Devaux, S R Shah, I Shestakova, A Shevaldin, O Shibolet, S Sokolov, K Souliotis, C W Spearman, T Staub, E A Strebkova, D Struck, K Tomasiewicz, L Undram, A J van der Meer, D van Santen, I Veldhuijzen, F G Villamil, S Willemse, F R Zuure, M O Silva, V Sypsa, E Gower
    J Viral Hepat. 2015 Jan; 22 Suppl 1:6-25
  • Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.
    E Gane, D Kershenobich, C Seguin-Devaux, P Kristian, I Aho, O Dalgard, I Shestakova, P Nymadawa, S Blach, S Acharya, A C Anand, M I Andersson, V Arendt, P Arkkila, O Baatarkhuu, K Barclay, Z Ben-Ari, C Bergin, F Bessone, N Blokhina, C R Brunton, G Choudhuri, V Chulanov, L Cisneros, E A Croes, Y A Dahgwahdorj, J R Daruich, N R Dashdorj, D Davaadorj, R J de Knegt, M de Vree, A C Gadano, E Gower, W Halota, A Hatzakis, C Henderson, P Hoffmann, J Hornell, D Houlihan, S Hrusovsky, P Jarcuska, K Kostrzewska, M Leshno, Y Lurie, A Mahomed, N Mamonova, N Mendez-Sanchez, J Mossong, S Norris, E Nurmukhametova, M Oltman, J Oyunbileg, Ts Oyunsuren, G Papatheodoridis, N Pimenov, M Prins, P Puri, S Radke, A Rakhmanova, H Razavi, K Razavi-Shearer, H W Reesink, E Ridruejo, R Safadi, O Sagalova, J F Sanchez Avila, R Sanduijav, V Saraswat, I Schreter, S R Shah, A Shevaldin, O Shibolet, M O Silva, S Sokolov, M Sonderup, K Souliotis, C W Spearman, T Staub, C Stedman, E A Strebkova, D Struck, V Sypsa, K Tomasiewicz, L Undram, A J van der Meer, D van Santen, I Veldhuijzen, F G Villamil, S Willemse, E Zuckerman, F R Zuure, N Prabdial-Sing, R Flisiak, C Estes
    J Viral Hepat. 2015 Jan; 22 Suppl 1:46-73
  • The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2.
    A Hatzakis, V Chulanov, A C Gadano, C Bergin, Z Ben-Ari, J Mossong, I Schreter, O Baatarkhuu, S Acharya, I Aho, A C Anand, M I Andersson, V Arendt, P Arkkila, K Barclay, F Bessone, S Blach, N Blokhina, C R Brunton, G Choudhuri, L Cisneros, E A Croes, Y A Dahgwahdorj, O Dalgard, J R Daruich, N R Dashdorj, D Davaadorj, R J de Knegt, M de Vree, C Estes, R Flisiak, E Gane, E Gower, W Halota, C Henderson, P Hoffmann, J Hornell, D Houlihan, S Hrusovsky, P Jarcuska, D Kershenobich, K Kostrzewska, P Kristian, M Leshno, Y Lurie, A Mahomed, N Mamonova, N Mendez-Sanchez, S Norris, E Nurmukhametova, P Nymadawa, M Oltman, J Oyunbileg, Ts Oyunsuren, G Papatheodoridis, N Pimenov, N Prabdial-Sing, M Prins, S Radke, A Rakhmanova, K Razavi-Shearer, H W Reesink, E Ridruejo, R Safadi, O Sagalova, J F Sanchez Avila, R Sanduijav, V Saraswat, C Seguin-Devaux, S R Shah, I Shestakova, A Shevaldin, O Shibolet, M O Silva, S Sokolov, M Sonderup, K Souliotis, C W Spearman, T Staub, C Stedman, E A Strebkova, D Struck, V Sypsa, K Tomasiewicz, L Undram, A J van der Meer, D van Santen, I Veldhuijzen, F G Villamil, S Willemse, E Zuckerman, F R Zuure, P Puri, H Razavi
    J Viral Hepat. 2015 Jan; 22 Suppl 1:26-45

2014 (1)